Mulmit

Editas Medicine, Inc.Editas Medicine, Inc.

EDIT Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3140,520,000-160,010,000-160,060,000-1.8
2024-12-3132,314,000-251,152,000-237,093,000-2.88
2023-12-3178,123,000-169,181,000-153,219,000-2.02
2022-12-3119,712,000-225,950,000-220,432,000-3.21
2021-12-3125,544,000-193,146,000-192,502,000-2.85

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-08Ory Daniel ScottEVP, Chief Medical Officer950,000
2026-09-03Parison AmySVP, Chief Financial Officer453
2026-09-03Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER709
2026-09-03O'Neill Gilmore NeilCEO5,124
2026-08-06Ellinor Patrick Thomas II103,400
2026-08-03Parison AmySVP, Chief Financial Officer678
2026-07-28Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER4,928
2026-06-17Connaughton Bernadette51,700
2026-06-17Hopfield Jessica51,700
2026-06-17Hirsch Andrew51,700
2026-06-17Scadden David51,700
2026-06-17Levy Elliott M.51,700

8-K events

FiledItems
2026-08-05Results of operations · Officer or director change · Financial statements and exhibits
2026-06-18Submission of matters to a vote
2026-05-26Entry into a material agreement · Other events · Financial statements and exhibits
2026-05-26Other events
2026-05-26Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-14Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-04-07Change in certifying accountant · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.